Sulat James R
SEC-identified person · CIK 1229448 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Mallinckrodt plc MNKTQ | Director | filed 2022 - 2023 |
| Max-1 Acquisition Corp XCUR | Director | filed 2021 - 2022 |
| Arch Therapeutics, Inc. ARTH | Director | filed 2015 - 2021 |
| Amag Pharmaceuticals, INC. AVM | Director | filed 2014 - 2020 |
| Momenta Pharmaceuticals INC MNTA | Director | filed 2008 - 2019 |
| Diadexus, Inc. vxgn | Director | filed 2015 - 2015 |
| Maxygen INC MAXY | Director · Former CEO & CFO | filed 2006 - 2013 |
| Codexis, INC. CDXS | Director | filed 2010 - 2010 |
| Memory Pharmaceuticals Corp MEMY | Director · President & CEO | filed 2006 - 2009 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.